Aktie PRON PRONOVA BIOPHARMA ASA
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Pronova BioPharma ASA

Aktien

PRON

NO0010382021

PRON

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Pronova BioPharma : Probe Metals to Acquire 100% Interest in the Monique Property, Val-d’Or East Project, Quebec
Pronova BioPharma : Probe Metals Completes $17 Million Bought Deal Private Placement
Pronova BioPharma : Probe Metals Upsizes Bought Deal Private Placement to $17.0 Million
Pronova BioPharma : Probe Metals Announces a $10 Million Bought Deal Private Placement of Flow-Through Units
Pronova BioPharma ASA : Notification of large trade/mandatory notification of trade
Pronova BioPharma AS : New Drug Application Approval for Lotriga® 2g in Japan
Pronova BioPharma AS : Pronova BioPharma ASA: US District Court rules in Pronova BioPharma's favour on Lovaza(TM) patents
Pronova BioPharma AS : Pronova BioPharma ASA: Strong Progress Towards Diversification
Pronova BioPharma AS : Pronova BioPharma ASA : Generic marketing authorisation in the UK
Pronova BioPharma AS : Pronova BioPharma ASA: Pronova BioPharma has published its Annual Report 2011
Pronova BioPharma AS : Presentation of Highlight Results from Phase 3 Trial of TAK-085 in Japan for the Treatment of Hyperlipidemia at the 76th Annual Scientific Meeting of the Japanese Circulation Society
Pronova BioPharma AS : Pronova BioPharma ASA: Expanding the Pharmaceutical Business into Clinical Nutrition
Pronova BioPharma AS : Pronova BioPharma ASA: Presentation of Q4 2011 results 14 February, 08:30 CET
Pronova BioPharma AS : Pronova BioPharma ASA : Mandatory Notification of Trade
Pronova BioPharma AS : Pronova BioPharma ASA: Strategic move into Omega-3 consumer market
Pronova BioPharma AS : Pronova BioPharma launches Consumer Healthcare business
Pronova BioPharma AS : Pronova BioPharma ASA : Presentation of Q3 2011 results 11 November, 08:30 AM CET
Pronova BioPharma AS : Mandatory Notification of Trade
Pronova BioPharma AS : PRC-4016 enters Phase I clinical trial for treatment of combined dyslipidemia
Pronova BioPharma AS : Mandatory notification of trade
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. PRON Aktie
  4. Nachrichten Pronova BioPharma ASA
  5. Andere Sprachen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT